Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports
Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with the matter.
More info
